Ferak Berlin Receives GMP Certification

Thomas Gruendemann, CEO and managing director, Ferak
Thomas Gruendemann, CEO and managing director, Ferak

Berlin, Germany-based provider of contract research & development and custom manufacturing services, Ferak, has received GMP certification by the Berlin State Office for Health and Social Affairs (LAGeSo) for one of its Active Pharmaceutical Ingredients (API). The GMP certificate that has been obtained by help of the Administrative Court of Berlin is immediately available upon request. Prior to the allocation of the certificate an independent GMP expert authorized by the German Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel - BfArM) confirmed full EU-GMP Part II compliance of the manufacturing process and equipment. Further API certificates will follow, the company reports.

“I am more than proud to say that the whole team of Ferak has been working hard to achieve this highest quality standard in the chemical/pharmaceutical industry”, says CEO and managing director Thomas Gruendemann. “The combination of our scientific expertise with both a detailed documentation system and the latest production and analytical equipment is the key to the high purity of our APIs. A clear GMP aim and a zero defect supply chain history with all of our pharmaceutical customers have lead us to this level of excellence which meets exactly our mission statement The Art of Making Purity”, Gruendemann concludes.

Company

Ferak Berlin GmbH

Lahnstr. 34
12055 Berlin
Germany

Company contact







Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.